Background and Objectives Restless legs syndrome (RLS) has been associated with anxiety, depression, insomnia, lifestyle factors and infections. We aimed to study the prevalence of symptoms of RLS during the COVID-19 pandemic versus pre-pandemic. We hypothesized that pre-existing RLS symptoms worsened and pandemic-related factors may have triggered new symptoms of RLS. Methods Adults (≥18 years) from fifteen countries across four continents participated in an online survey between May and August 2020. The harmonized questionnaire included a validated single question on RLS with response alternatives from 1 to 5 on a scale from never to every/almost every evening or night. Other measures were the Insomnia Severity Index (ISI), measures of symptoms of anxiety (GAD-2) and depression (PHQ-2), and questions on different pandemic-related factors. Results Altogether, 17 846 subjects (63.8% women) were included in the final analyses. The mean age was 41.4 years (SD 16.1). During the pandemic, symptoms of RLS (≥3 evenings/nights per week) were more common 9.1% (95% CI 8.7 – 10.1) compared to 5.4% (95% CI 4.9 – 6.0) before the pandemic (P<0.0001). Alltogether 1.3% (95% CI 1.1 – 1.6) respondents had new-onset symptoms (≥ 3 evenings/nights per week). Moderate-severe insomnia was strongly associated with RLS symptoms. The occurrences of new-onset RLS symptoms were 5.6% (95% CI 0.9 – 13.0) for participants reporting COVID-19 and 1.1% (95% CI 0.7 – 1.5) for non-COVID-19 participants. In the fully adjusted logistic regression model, the occurrence of new-onset RLS symptoms was associated with younger age, social restrictions and insomnia severity. In a similar analysis, RLS symptoms (≥3 evenings/nights per week) were associated with lower education, financial hardship, sleep apnea symptoms, use of hypnotics, insomnia severity, symptoms of depression and possible post-traumatic stress disorder. Discussion Our findings indicate that RLS symptoms were more common during the pandemic than before. Usually, the prevalence of RLS increases with age. However, during the pandemic, new-onset symptoms of RLS were more common in younger age groups. This may be due to the pandemic-related factors being more pronounced in the younger compared to the older. The association between insomnia, psychiatric symptoms and RLS warrants clinical attention.

Restless legs symptoms increased during COVID-19 pandemic. International ICOSS-survey / Partinen, Eemil; Inoue, Yuichi; Sieminski, Mariusz; Merikanto, Ilona; Bjorvatn, Bjørn; Bolstad, Courtney J.; Chung, Frances; Gennaro, Luigi De; Espie, Colin A.; Holzinger, Brigitte; Matsui, Kentaro; Mota-Rolim, Sergio; Morin, Charles; Nadorff, Michael R.; Penzel, Thomas; Plazzi, Giuseppe; Wing, Y. K.; Dauvilliers, Yves; Partinen, Markku. - In: SLEEP MEDICINE. - ISSN 1389-9457. - 119:(2024), pp. -389. [10.1016/j.sleep.2024.04.016]

Restless legs symptoms increased during COVID-19 pandemic. International ICOSS-survey

Gennaro, Luigi De;
2024

Abstract

Background and Objectives Restless legs syndrome (RLS) has been associated with anxiety, depression, insomnia, lifestyle factors and infections. We aimed to study the prevalence of symptoms of RLS during the COVID-19 pandemic versus pre-pandemic. We hypothesized that pre-existing RLS symptoms worsened and pandemic-related factors may have triggered new symptoms of RLS. Methods Adults (≥18 years) from fifteen countries across four continents participated in an online survey between May and August 2020. The harmonized questionnaire included a validated single question on RLS with response alternatives from 1 to 5 on a scale from never to every/almost every evening or night. Other measures were the Insomnia Severity Index (ISI), measures of symptoms of anxiety (GAD-2) and depression (PHQ-2), and questions on different pandemic-related factors. Results Altogether, 17 846 subjects (63.8% women) were included in the final analyses. The mean age was 41.4 years (SD 16.1). During the pandemic, symptoms of RLS (≥3 evenings/nights per week) were more common 9.1% (95% CI 8.7 – 10.1) compared to 5.4% (95% CI 4.9 – 6.0) before the pandemic (P<0.0001). Alltogether 1.3% (95% CI 1.1 – 1.6) respondents had new-onset symptoms (≥ 3 evenings/nights per week). Moderate-severe insomnia was strongly associated with RLS symptoms. The occurrences of new-onset RLS symptoms were 5.6% (95% CI 0.9 – 13.0) for participants reporting COVID-19 and 1.1% (95% CI 0.7 – 1.5) for non-COVID-19 participants. In the fully adjusted logistic regression model, the occurrence of new-onset RLS symptoms was associated with younger age, social restrictions and insomnia severity. In a similar analysis, RLS symptoms (≥3 evenings/nights per week) were associated with lower education, financial hardship, sleep apnea symptoms, use of hypnotics, insomnia severity, symptoms of depression and possible post-traumatic stress disorder. Discussion Our findings indicate that RLS symptoms were more common during the pandemic than before. Usually, the prevalence of RLS increases with age. However, during the pandemic, new-onset symptoms of RLS were more common in younger age groups. This may be due to the pandemic-related factors being more pronounced in the younger compared to the older. The association between insomnia, psychiatric symptoms and RLS warrants clinical attention.
2024
restless legs syndrome; RLS; prevalence sleep disorders: insomnia: psychiatric disorders; COVID-19
01 Pubblicazione su rivista::01a Articolo in rivista
Restless legs symptoms increased during COVID-19 pandemic. International ICOSS-survey / Partinen, Eemil; Inoue, Yuichi; Sieminski, Mariusz; Merikanto, Ilona; Bjorvatn, Bjørn; Bolstad, Courtney J.; Chung, Frances; Gennaro, Luigi De; Espie, Colin A.; Holzinger, Brigitte; Matsui, Kentaro; Mota-Rolim, Sergio; Morin, Charles; Nadorff, Michael R.; Penzel, Thomas; Plazzi, Giuseppe; Wing, Y. K.; Dauvilliers, Yves; Partinen, Markku. - In: SLEEP MEDICINE. - ISSN 1389-9457. - 119:(2024), pp. -389. [10.1016/j.sleep.2024.04.016]
File allegati a questo prodotto
File Dimensione Formato  
Partinen_symptoms_COVID-19_ ICOSS-survey_2024.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 4.2 MB
Formato Adobe PDF
4.2 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1709710
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact